Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Insert the needle using a smooth, dart-like motion until it reaches the muscle
5.4 Acute Kidney Injury Due to Volume Depletion There have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, in patients treated with GLP-1 receptor agonists, BYETTA [see Adverse Reactions (6.2)]
In the landmark Phase 3 VESALIUS-CV trial (12,000+ patients), adding Repatha to standard cholesterol-lowering therapy significantly reduced the risk of: Heart attacks Ischemic strokes Coronary deaths This makes Repatha the first PCSK9 inhibitor to demonstrate preventive benefits before heart disease strikes a true paradigm shift in cardiovascular care
This is not about stopping everything
S., Ferreira, D., Paige, E., Gedye, C., & Boyle, M
US$ 23.43
US$ 29.20
US$ 24.35
US$ 26.19
US$ 27.28
